USE OF WRITHING TEST FOR EVALUATING ANALGESIC ACTIVITY OF NARCOTIC ANTAGONISTS.
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D000818:Animals; D058633:Antipyretics; D001681:Biological Assay; D003496:Cyclazocine; D007977:Levallorphan; D051379:Mice; D009020:Morphine; D009269:Nalorphine; D009292:Narcotic Antagonists; D010111:Oxymorphone; D010423:Pentazocine; D010600:Pharmacology; D011809:Quinones; D012106:Research; D014116:Toxicology
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D058633:Antipyretics; D009292:Narcotic Antagonists; D011809:Quinones; D007977:Levallorphan; D009020:Morphine; D010111:Oxymorphone; D003496:Cyclazocine; D010423:Pentazocine; D009269:Nalorphine
ANALGESICS AND ANTIPYRETICS; BIOLOGICAL ASSAY; CYCLAZOCINE; EXPERIMENTAL LAB STUDY; LEVALLORPHAN; MICE; MORPHINE; NALORPHINE; NARCOTIC ANTAGONISTS; OXYMORPHONE; PENTAZOCINE; PHARMACOLOGY; QUINONES; TOXICOLOGIC REPORT